The enigma of the SARS-CoV-2 microcirculation dysfunction: evidence for modified endothelial junctions.
L. Bouillet, M. Benmarce, C. Guerin, L. Bouvet, O. Garnier, D. Martin, I. Vilgrain
This paper investigates how SARS-CoV-2 affects endothelial junctions by targeting VE-cadherin and ACE2, finding increased soluble fragments in severe COVID-19 patients.
bioRxiv · Apr 24, 2023 · PreprintBiochemistry